Jean-Claude do Rego Selected Research

Immunoglobulins (Immunoglobulin)

1/2016	Increased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia.
9/2012	Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Claude do Rego Research Topics

Disease

6	Body Weight (Weight, Body) 01/2021 - 09/2012
4	Anorexia 01/2021 - 06/2015
3	Obesity 01/2020 - 12/2019
2	Heart Failure 01/2021 - 05/2014
2	Anorexia Nervosa 01/2021 - 06/2015
2	Dysbiosis 01/2021 - 01/2021
2	Catalepsy 10/2019 - 01/2013
2	Depressive Disorder (Melancholia) 09/2012 - 04/2007
1	Weight Gain 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Overweight 01/2020
1	Hyperglycemia 01/2020
1	Schizophrenia (Dementia Praecox) 10/2019
1	Neurobehavioral Manifestations 10/2019
1	Colitis 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Neoplasms (Cancer) 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Cachexia 01/2016
1	Mucositis 01/2016
1	Starvation 06/2015
1	Feeding and Eating Disorders (Eating Disorder) 03/2015
1	Sepsis (Septicemia) 05/2014
1	Inflammation (Inflammations) 05/2014
1	Hyperphagia (Overeating) 01/2013
1	Gliosis 01/2013
1	Pain (Aches) 02/2010
1	Hypothermia 12/2005

Drug/Important Bio-Agent (IBA)

4	GhrelinIBA 01/2016 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2019
3	Immunoglobulin G (IgG)IBA 01/2016 - 01/2013
2	Appetite Depressants (Anorectics)IBA 01/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2015
2	Insulin (Novolin)FDA Link 01/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 03/2015
2	Neuropeptide YIBA 01/2021 - 09/2012
2	Neuroprotective AgentsIBA 10/2019 - 01/2018
2	Apomorphine FDA Link 10/2019 - 12/2005
2	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 09/2012
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021
1	Biological FactorsIBA 01/2021
1	finerenoneIBA 01/2021
1	NeuropeptidesIBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2020
1	Orlistat (Xenical)FDA Link 12/2019
1	Ketamine FDA LinkGeneric 10/2019
1	ImidazolidinesIBA 10/2019
1	Glutamic Acid (Glutamate)FDA Link 10/2019
1	3- (2- chloro- 6- fluorobenzyl)- imidazolidine- 2,4- dioneIBA 10/2019
1	Antipsychotic Agents (Antipsychotics)IBA 10/2019
1	Sulfonic AcidsIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	Hormones (Hormone)IBA 01/2016
1	Peptides (Polypeptides)IBA 06/2015
1	Therapeutic UsesIBA 05/2014
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 05/2014
1	LipopolysaccharidesIBA 05/2014
1	barbituric acid (barbiturate)IBA 01/2013
1	AutoantibodiesIBA 09/2012
1	Analgesics (Analgesic Drugs)IBA 02/2010
1	Antidepressive Agents (Antidepressants)IBA 04/2007
1	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2007

Therapy/Procedure

1	Ovariectomy (Oophorectomy) 01/2021
1	Drug Therapy (Chemotherapy) 01/2016
1	Punctures 05/2014
1	Ligation 05/2014
1	Transplantation 01/2013
1	Therapeutics 02/2010